Back to ABIVAXInsider 
Company
TRUFFLE CAPITAL SAS — ABIVAX
Filing 2024DD999290Published 7 Oct 2024France public disclosures
InitialEffective
Summary
TRUFFLE CAPITAL SAS
Philippe Pouletty, Membre du conseil d'administration
ABIVAX
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
CompanyABIVAX
ISINFR0012333284
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
Reported buys
€0.00
Reported sales
€1,070,070.00
Net buy/sell
-€1,070,070.00
Other reported value
€0.00
Gross reported value
€1,070,070.00
Transactions
3
Transactions
| Execution date | Direction | Nature | Instrument | Settlement | Quantity | Unit price | Total | Venue |
|---|---|---|---|---|---|---|---|---|
| 1 Oct 2024 | SellCession / SELL | DISPOSAL | SHARE | UNKNOWN | 27,630 | €9.00 | €248,670.00 | XPAR |
| 1 Oct 2024 | SellCession / SELL | DISPOSAL | SHARE | UNKNOWN | 60,000 | €9.10 | €546,000.00 | XPAR |
| 1 Oct 2024 | SellCession / SELL | DISPOSAL | SHARE | UNKNOWN | 30,000 | €9.18 | €275,400.00 | XPAR |
Sell
Execution date1 Oct 2024Cession / SELL
DISPOSAL · SHARE · UNKNOWN · XPAR
- Quantity
- 27,630
- Unit price
- €9.00
- Total
- €248,670.00
Sell
Execution date1 Oct 2024Cession / SELL
DISPOSAL · SHARE · UNKNOWN · XPAR
- Quantity
- 60,000
- Unit price
- €9.10
- Total
- €546,000.00
Sell
Execution date1 Oct 2024Cession / SELL
DISPOSAL · SHARE · UNKNOWN · XPAR
- Quantity
- 30,000
- Unit price
- €9.18
- Total
- €275,400.00
Evidence
- AMF · France2024DD999290
Corrections
Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.